|
Wayne Yetter has served as a Director of Synvista since July 2006. Mr. Yetter has served as Chief Executive Officer of Verispan LLC a healthcare information company founded by Quintiles Transnational Corp. and McKesson Corp since September 2005. From November 2004 through September 2005 Mr. Yetter served as President and Chief Executive Officer of Odyssey Pharmaceuticals Inc. to assist Odyssey’s parent PLIVA d.d. implement its strategy to exit the proprietary pharmaceutical business. Mr. Yetter has built and led a variety of multi-million dollar businesses and pharmaceutical operations for some of the largest companies in the world. After serving in Vietnam Mr. Yetter began his career in the pharmaceuticals industry in 1970 as a sales representative for Pfizer. From Pfizer he joined Merck & Co in 1977 where he led the Marketing Operations Group and then became President of the Asia Pacific region before starting the new company Astra Merck in 1991 as President and CEO. Under his leadership the company’s product Prilosec grew to be the #1 pharmaceutical product in the U.S. at the time. Mr. Yetter then joined Novartis Pharmaceuticals in 1997 where he was President and CEO of the U.S. pharmaceutical business. In 1999 he joined IMS and later led its spinout company Synavant where he was Chairman and CEO for three years before the company merged with Dendrite International in 2003. Following the merger Mr. Yetter founded and has acted as principal of BioPharm Advisory LLC since September 2003. Mr. Yetter was formerly Chairman of the Board for Transkaryotic Therapies Inc. which was acquired by Shire Pharmaceuticals in 2005. Mr. Yetter received his BA in Biology from the Wilkes University and his MBA from Bryant University | 